Trans 10, cis 12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARγ modulator

Journal of Lipid Research

Volumn 44, Issue 8, 2003, Pages 1441-1452

  Granlund, Linda ^a   Juvet, Lene K ^a   Pedersen, Jan I ^a   Nebb, Hilde I ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Darglitazone; Fatty acid binding protein; Liver X receptor

Indexed keywords

CONJUGATED LINOLEIC ACID; DARGLITAZONE; FATTY ACID BINDING PROTEIN; LINOLEIC ACID; LIVER X RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ADAPTOR PROTEIN; CELL RECEPTOR; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BODY COMPOSITION; BODY FAT; HUMAN; HUMAN CELL; LEAN BODY WEIGHT; LIPID COMPOSITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; ANIMAL; BINDING COMPETITION; CELL LINE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; METABOLISM; TIME;

ADAPTOR PROTEIN COMPLEX 2; ADIPOCYTES; ANIMALS; BINDING, COMPETITIVE; CELL LINE; DNA-BINDING PROTEINS; DOWN-REGULATION; ENZYME ACTIVATION; HUMANS; LINOLEIC ACIDS, CONJUGATED; MICE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLIDINEDIONES; TIME FACTORS; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 0141851324     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300120-JLR200     Document Type: Article

References (54)

1. Fruhbeck, G., J. Gomez-Ambrosi, F. J. Muruzabal, and M. A. Burrel. 2001. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 280: E827-E847.
2. Must, A., J. Spadano, E. H. Coakley, A. E. Field, G. Colditz, and W. H. Dietz. 1999. The disease burden associated with overweight and obesity. JAMA. 282: 1523-1529.
3. Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14: 1293-1307.
4. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O Wilkison, T. M. Willson, and S. A. Kliever. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270: 12953-12956.
5. Tontonoz, P., E. Hu, J. Devine, E. G. Beale, and B. M. Spiegelman. 1995. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol. Cell. Biol. 15: 351-357.
6. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234.
7. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 79: 1147-1156.
8. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1995. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator-activated receptor gamma. Curr. Opin. Genet. Dev. 5: 571-576.
9. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman, and R. M. Evans. 1995. 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell. 83: 803-812.
10. Xu, H. E., M. H. Lambert, V. G. Montana, D.J. Parks, S. G. Blanchard, P. J. Brown, D. D. Sternbach, J. M. Lehmann, G. B. Wisely, T. M. Willson, S. A. Kliewer, and M. V. Milburn. 1999. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell. 3: 397-403.
11. Willson, T. M., P. J. Brown, D. D. Sternbach, and B. R. Henke. 2000. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43: 527-550.
12. Hallakou, S., L. Doare, F. Foufelle, M. Kergoat, M. Guerre-Millo, M. F. Berthault, I. Dugail, J. Morin, J. Auwerx, and P. Ferre. 1997. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes. 46: 1393-1399.
13. Mauvais-Jarvis, F., F. Andreelli, H. Hanaire-Broutin, B. Charbonnel, and J. Girard. 2001. Therapeutic perspectives for type 2 diabetes mellitus: molecular and clinical insights. Diabetes Metab. 27: 415-423.
14. Mukherjee, R., P. A. Hoener, L. Low, J. Bilakovics, K. Klausing, D. E. Mais, A. Faulkner, G. E. Croston, and J. R. Paterniti, Jr. 2000. A selective peroxisome proliferator-activated receptor-γ (PPARγ) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol. Endocrinol. 14: 1425-1433.
15. Kepler, C. R., K. P. Hirons, J. J. McNeill, and S. B. Tove. 1966. Intermediates and products of the biohydrogenation of linoleic acid by butyrinvibrio fibrisolvens. J. Biol. Chem. 245: 3612-3620.
16. Chin, S. F., W. Liu, J. M. Storkson, Y. L. Ha, and M. W. Pariza. 1992. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J. Food Compos. Anal. 5: 185-197.
17. de Deckere, E. A., J. M. van Amelsvoort, G. P. McNeill, and P. Jones. 1999. Effects of conjugated linoleic acid (CLA) isomers on lipid levels and peroxisome proliferation in the hamster. Br. J. Nutr. 82: 309-317.
18. Belury, M. 1995. Conjugated dienoic linoleate: a polyunsaturated fatty acid with unique chemoprotective properties. Nutr. Rev. 53: 83-89.
19. Lee, K. N., D. Kritchevsky, and M. W. Pariza. 1994. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis. 108: 19-25.
20. Nicolosi, R. J., E. J. Rogers, D. Kritchevsky, J. A. Scimeca, and P. J. Huth. 1997. Dietary conjugated linoleic acid reduces plasma lipoprotein and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery. 22: 266-277.
21. Houseknecht, K. L., J. P. Vanden Heuvel, S. Y. Moya-Camarena, C. P. Portocarrero, L. W. Peck, K. P. Nickel, and M. A. Belury. 1998. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 244: 678-682.
22. Park, Y., K. J. Albright, W. Liu, J. M. Storkson, M. E. Cook, and M. W. Pariza. 1997. Effect of conjugated linoleic acid on body composition in mice. Lipids. 32: 853-858.
23. West, D. B., J. P. Delany, P. M. Camet, F. Blohm, A. A. Truett, and J. Scimeca. 1998. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am. J. Physiol. 275: R667-R672.
24. Park, Y., J. M. Storkson, K. J Albright, W. Liu, and M. W. Pariza. 1999. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids. 34: 235-241.
25. DeLany, J. P., F. Blohm, A. A. Truett, J. A. Scimeca, and D. B. West. 1999. Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. Am. J. Physiol. 276: R1172-R1179.
26. Ostrowska, E., M. Muralitharan, R. F. Cross, D. E. Baumann, and F. R. Dunshea, 1999. Dietary conjugated linoleic acids increase lean tissue and decrease fat deposition in growing pigs. J. Nutr. 129: 2037-2042.
27. Gavino, V., G. Gavino, M. Leblanc, and B. Tuchweber. 2000. An isomeric mixture of conjugated linoleic acid but not pure cis-9, trans-11 octadecadienoic acid affects body weight gain and plasma lipids in hamsters. J. Nutr. 130: 27-29.
28. Evans, M., C. Geigerman, J. Cook, L. Curtis, B. Kuebler, and M. McIntosh. 2000. Conjugated linoleic acid suppresses triglyceride accumulation and induces apoptosis in 3T3-L1 preadipocytes. Lipids. 35: 899-910.
29. Brown, M., M. Evans, and M. McIntosh. 2001. Linoleic acid partially restores the triglyceride content of conjugated linoleic acid-treated cultures of 3T3-L1 preadipocytes. J. Nutr. Biochem. 12: 381-387.
30. Brown, J. M., Y. D. Halvorsen, Y. R. Lea-Currie, C. Geigerman, and M. McIntosh. 2001. Trans-10, cis12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue. J. Nutr. 131: 2316-2321.
31. Moya-Camarena, S. Y., J. P. Vanden Heuvel, S. G. Blanchard, L. A. Leesnitzer, and M. A. Belury. 1999. Conjugated linoleic acid is a potent naturally occuring ligand and activator of PPARα. J. Lipid Res. 40: 1426-1433.
32. Lin, F. T., and M. D. Lane. 1992. Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev. 6: 533-544.
33. Wabitsch, M., R. E. Brenner, I. Melzner, M. Braun, P. Moller, E. Heinze, K. M. Debatin, and H. Hauner. 2001. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int. J. Obes. 25: 8-15.
34. Tobin, K. A. R., H. H. Steineger, S. Alberti, Ø. Spydevold, J. Auwerx, J-Å. Gustafsson, and H. I. Nebb. 2000. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-α. Mol. Endocrinol. 14: 741-752.
35. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52: 456-467.
36. Sørensen, H. N., K. M. Gautvik, J. Bremer, and O. Spydevold. 1992. Induction of three peroxisomal β-oxidation enzymes is synergistically regulated by dexamethasone and fatty acids, and counter-acted by insulin in Morris 7800C1 hepatoma cells in culture. Eur. J. Biochem. 208: 705-711.
37. Harris, P. K., and R. F. Kletzien. 1994. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene. Mol. Pharmacol. 45: 439-445.
38. Apfel, R., D. Benbrook, E. Lernhardt, M. A. Ortiz, G. Salberg, and M. Pfahl. 1994. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol. Cell. Biol. 14: 7025-7035.
39. Wu, Z., N. L. Bucher, and S. R. Farmer. 1996. Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3-L1 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol. Cell. Biol. 16: 4128-4136.
40. Chawla, A., W. A. Boisvert, C. H. Lee, B. A. Lafitte, Y. Barak, S. B. Joseph, D. Liao, L. Nagy, P. A. Edwards, L. K. Curtiss, R. M. Evans, and P. Tontonoz. 2001. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell. 7: 161-171.
41. Juvet, L. K., S. M. Andresen, G. Schuster, K. T. Dalen, K. A. R. Tobin, K. Hollung, F. Haugen, S. Jacinto, S. M. Ulven, K. Bamberg, J. Å. Gustafsson, and H. I. Nebb. 2003. On the role of liver X receptor in lipid accumulation in adipocytes. Mol. Endocrinol. 17: 172-182.
42. Kliewer, S. A., J. M. Lenhard, T. M. Willson, I. Patel, D. C. Morris, and J. M. Lehmann. 1995. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell. 83: 813-819.
43. Tontonoz, P., L. Nagy, G. Alvarez, V. A. Thomazy, and R. M. Evans. 1998. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93: 241-252.
44. Nagy, L., P. Tontonoz, J. G. Alvarez, H. Chen, and R. M. Evans. 1998. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 93: 229-240.
45. Thuillier, P., G. J. Anchiraico, K. P. Nickel, R. E. Maldve, I. Gimenez-Conti, S. J. Muga, K. L. Liu, S. M. Fisher, and M. A. Belury. 2000. Activators of peroxisome proliferator-activated receptor-alpha partially inhibit mouse skin tumor promotion. Mol. Carcinog. 29: 134-142.
46. Belury, M. A., S. Y. Moya-Camarena, M. Lu, L. Shi, L. M. Leesnitzer, and S. G. Blanchard. 2002. Conjugated linoleic acid is an activator and ligand for peroxisome proliferator-activated receptor-gamma (PPARγ). Nutr. Res. 22: 817-824.
47. Peters, J. M., Y. Park, F. Gonzalez, and M. W. Pariza. 2001. Influence of conjugated linoleic acid on body composition and target gene expression in peroxisome proliferator-activated receptor α-null mice. Biochim. Biophys. Acta. 1533: 233-242.
48. Brodie, A. E., V. A. Manning, K. R. Ferguson, D. E. Jewell, and C. Y. Hu. 1999. Conjugated linoleic acid inhibits differentiation of pre- and post-confluent 3T3-L1 preadipocytes but inhibits cell proliferation only in preconfluent cells. J. Nutr. 129: 602-606.
49. Choi, Y., Y. C. Kim, Y. B. Han, Y. Park, M. W. Pariza, and J. M. Ntambi. 2000. The trans-10,cis-12 isomer of conjugated linoleic acid downregulates stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. J. Nutr. 130: 1920-1924.
50. Evans, M., Y. Park, M. Pariza, L. Curtis, B. Kuebler, and M. McIntosh. 2001. Trans-10, cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor γ2 and aP2 expression in 3T3-L1 preadipocytes. Lipids. 36: 1223-1232.
51. Wright, H. M., C. B. Clish, T. Mikami, S. Hauser, K. Yanagi, R. Hiramatsu, C. N. Serhan, and B. M. Spiegelman. 2000. A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. J. Biol. Chem. 275: 1873-1877.
52. Camp, H. S., A. Chaudhry, and T. Leff. 2001. A novel potent antagonist of peroxisome proliferator-activated receptor γ blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes. Endocrinology. 142: 3207-3213.
53. Oberfield, J. L., J. L. Collins, C. P. Holmes, D. M. Goreham, J. P. Cooper, J. E. Cobb, J. M. Lenhard, E. A. Hull-Ryde, C. P. Mohr, S. G. Blanchard, D. J. Parks, L. B. Moore, J. M. Lehmann, K. Plunket, A. B. Miller, M. V. Milburn, S. A. Kliewer, and T. M. Willson. 1999. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. Proc. Natl. Acad. Sci. USA. 96: 6102-6106.
54. Ou, J., H. Tu, B. Shan, A. Luk, R. A. DeBose-Boyd, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA. 98: 6027-6032.